Harvard thoracic pathology 2024

Lung Cancer Classification and Diagnosis

• Updates in classification and diagnosis in lung cancer
• Therapeutically relevant molecular subsets of lung cancer
• Current update in thoracic oncology and implications for pathologists
• What thoracic surgeons need from pathologists
• Diagnosis of lung cancer in small biopsies and cytology
• Variants of lung adenocarcinoma and squamous cell carcinoma
• Practical diagnostic strategies for lung cancer classification and reporting

Immunohistochemistry, Predictive Markers and Molecular Testing

• Immunohistochemistry for lung cancer diagnosis
• Immunohistochemistry for predictive markers in lung cancer
• Update on IASLC/AMP/CAP molecular guidelines for lung tumors
• Tissue requirements for clinical management of advanced lung cancer patients
• Integrating molecular analysis with morphology and immunohistochemistry
• Practical considerations in small biopsy and cytology specimens
• Using molecular results to support treatment-relevant diagnosis

Thoracic Oncology, Staging and Multidisciplinary Tumor Board

• Staging of lung cancer
• Updated staging guidelines and clinical implications
• Radiologic-pathologic correlations in thoracic neoplasia
• Minimally invasive endobronchial techniques including robotic bronchoscopy
• Thoracic tumor board discussion
• Communication between pathology, surgery, oncology, radiology, and pulmonology
• Multidisciplinary approach to difficult thoracic cancer cases

Neuroendocrine Tumors and Tumor-Like Lung Lesions

• Neuroendocrine tumors of the lung
• Diagnostic criteria and classification of pulmonary neuroendocrine neoplasms
• Tumor-like lesions of the lung
• Distinguishing neoplastic from reactive and inflammatory mimics
• Clinical and radiologic correlation in tumor-like lesions
• Diagnostic pitfalls in challenging lung lesions
• Case-based learning for complex thoracic pathology presentations

Interstitial Lung Disease: Pathology, Radiology and Clinical Correlation

• Pathology of interstitial lung disease
• Radiology of interstitial lung disease
• Clinical profile of interstitial lung disease
• International guidelines for care of patients with interstitial lung disease
• The pathologist’s role in multidisciplinary discussion for interstitial lung disease
• Multidisciplinary approach to interstitial lung disease diagnosis
• Integration of clinical, radiologic, and pathologic findings in ILD cases

Inflammatory, Systemic and Acute Lung Disease

• The spectrum of hypersensitivity reactions in the lung
• Lung manifestations of systemic disorders including IgG4-related disease and vasculitis
• Diagnostic approach to acute lung injury
• COVID-related lung disease
• Inflammatory and immune-mediated lung pathology
• Clinicopathologic correlation in acute and chronic lung injury
• Practical diagnostic considerations in complex inflammatory thoracic disease

Pulmonary Infection and Lung Transplantation

• Pulmonary infection in thoracic pathology practice
• Recognizing infectious patterns in lung tissue
• Differentiating infection from inflammatory and neoplastic mimics
• Pathology of lung transplantation
• Transplant-related lung pathology and diagnostic challenges
• Clinical correlation in transplant and infection-related cases
• Practical approach to thoracic infection and transplant biopsies

Intraoperative Consultation and Quality Issues

• Pitfalls in intraoperative consultation for thoracic diseases
• Quality assurance issues in thoracic pathology
• Frozen section challenges and diagnostic limitations
• Communication with surgeons during intraoperative consultation
• Reducing diagnostic error in thoracic specimens
• Best practices for quality and safety in thoracic pathology workflow
• Practical pearls for difficult real-time diagnostic decisions

Mesothelioma and Mediastinal Tumors

• Malignant mesothelioma
• Current diagnostic criteria for mesothelioma
• Clinicopathologic staging system for mesothelioma
• Unusual mediastinal and thoracic epithelial tumors
• NUT, SMARCA4, germ cell, and other unusual thoracic tumors
• Thymomas and their differential diagnoses
• Practical distinction of mediastinal tumors and mimics

Pulmonary and Mediastinal Lymphomas

• Pulmonary and mediastinal lymphomas
• Approach to lymphoid lesions in thoracic specimens
• Differentiating lymphoma from inflammatory and epithelial mimics
• Clinical and pathologic correlation in mediastinal lymphoid disease
• Immunohistochemical and ancillary testing considerations
• Diagnostic pearls for challenging lymphoma cases
• Reporting considerations for thoracic lymphoid neoplasms

Tracheal, Salivary Gland-Type and Soft Tissue Tumors

• Tumors of the trachea
• Salivary gland-type tumors of the thorax
• Thoracic soft tissue tumors
• Diagnostic approach to rare thoracic neoplasms
• Use of morphology, immunohistochemistry, and molecular findings
• Differential diagnosis of uncommon thoracic tumors
• Practical case-based review of rare thoracic lesions

Mystery Cases and Expert Case Discussions

• Mystery thoracic pathology cases
• Expert faculty discussion of challenging diagnostic problems
• Case-based learning across lung, pleura, mediastinum, and thoracic soft tissue
• Diagnostic pearls and pitfalls from real-world cases
• Multidisciplinary problem-solving strategies
• Practical application of updated guidelines and diagnostic criteria
• Closing synthesis of major thoracic pathology updates

This course is best suited for pathologists, pulmonologists, thoracic surgeons, radiologists, oncologists, specialty physicians, physician assistants, nurse practitioners, residents, fellows, and physicians in training.

Topics include lung cancer classification, molecular subsets, thoracic oncology, immunohistochemistry, lung cancer staging, small biopsies and cytology, radiologic-pathologic correlation, neuroendocrine tumors, interstitial lung disease, pulmonary infection, lung transplantation, mesothelioma, mediastinal tumors, thymomas, lymphomas, tracheal tumors, salivary gland-type tumors, thoracic soft tissue tumors, and mystery cases.

Yes. The course reviews molecular subsets of lung cancer, molecular guidelines for lung tumors, predictive markers, and the role of molecular testing in clinical management.

Yes. The course emphasizes morphology, immunohistochemistry, molecular testing, small biopsy diagnosis, cytology, staging, radiologic correlation, multidisciplinary discussion, and diagnostic pitfalls.

Yes. This product is provided as recorded course access so you can review the material at your own pace.

No. CME credits and certificates are not included with this course package.

You can contact support at support@getmedicalcourses.com.